BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37216165)

  • 81. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.
    Tougeron D; Mouillet G; Trouilloud I; Lecomte T; Coriat R; Aparicio T; Des Guetz G; Lécaille C; Artru P; Sickersen G; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Zaanan A
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26839356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy].
    Shi Y; Chen L; Li J; Lü YL; Jiao SC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):375-82. PubMed ID: 20868593
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.
    Pagès F; André T; Taieb J; Vernerey D; Henriques J; Borg C; Marliot F; Ben Jannet R; Louvet C; Mineur L; Bennouna J; Desrame J; Faroux R; Kirilovsky A; Duval A; Laurent-Puig P; Svrcek M; Hermitte F; Catteau A; Galon J; Emile JF
    Ann Oncol; 2020 Jul; 31(7):921-929. PubMed ID: 32294529
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
    Baik H; Lee SM; Seo SH; An MS; Kim KH; Bae KB; Oh MK; Hong KH
    ANZ J Surg; 2018 Jun; 88(6):587-591. PubMed ID: 28687025
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
    Jacquemier J; Boher JM; Roche H; Esterni B; Serin D; Kerbrat P; Andre F; Finetti P; Charafe-Jauffret E; Martin AL; Campone M; Viens P; Birnbaum D; Penault-Llorca F; Bertucci F
    Breast Cancer Res; 2011; 13(6):R109. PubMed ID: 22044691
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
    Klintman M; Bendahl PO; Grabau D; Lövgren K; Malmström P; Fernö M;
    Mod Pathol; 2010 Feb; 23(2):251-9. PubMed ID: 19935641
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
    Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
    Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer.
    Peng J; Li W; Fan W; Zhou W; Zhu Y; Li X; Pan Z; Lin X; Lin J
    Front Pharmacol; 2020; 11():583091. PubMed ID: 33071795
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.
    den Uil SH; van den Broek E; Coupé VMH; Vellinga TT; Delis-van Diemen PM; Bril H; Belt EJT; Kranenburg O; Stockmann HBAC; Belien JAM; Meijer GA; Fijneman RJA
    BMC Gastroenterol; 2019 Aug; 19(1):146. PubMed ID: 31420015
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effect of the duration of the capecitabine regimen following colon cancer surgery in an elderly population: a retrospective cohort study.
    Chen W; Dong H; Wang G; Chen J; Wang W
    World J Surg Oncol; 2021 Aug; 19(1):238. PubMed ID: 34380513
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer.
    Chen W; Dong S; Liu X; Wang G; Xu S; Lei S; Zhuo S; Yan J
    Dis Colon Rectum; 2021 May; 64(5):563-575. PubMed ID: 33538520
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A novel nomogram model based on Ki-67 characteristic expression to predict prognosis in head and neck squamous cell carcinoma.
    Wang T; Xue L; Li Z; Hong Z; Hu N; Li Y; Yan B
    Front Oncol; 2024; 14():1376498. PubMed ID: 38651151
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Prognostic Importance of Ki-67 in Gastrointestinal Carcinomas: A Meta-analysis and Multi-omics Approach.
    Razmi M; Tajik F; Hashemi F; Yazdanpanah A; Hashemi-Niasari F; Divsalar A
    J Gastrointest Cancer; 2024 Jun; 55(2):599-624. PubMed ID: 38411875
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association between Ki67 expression and therapeutic outcome in colon cancer.
    Liu Q; Ran D; Wang L; Feng J; Deng W; Mei D; Peng Y; Du C
    Oncol Lett; 2023 Jun; 25(6):272. PubMed ID: 37216165
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer.
    Yan S; Shun-Chang J; Li C; Jie L; Ya-Li L; Ling-Xiong W
    BMC Cancer; 2010 Nov; 10():621. PubMed ID: 21067592
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
    Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
    Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.